reglab/housing_qa huggingface dataset:
LA Rev Stat § 40:1079.15 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1079.15. Parental involvement in counseling

RS 1079.15 - Parental involvement in counseling  Any school or facility that provides preventive counseling or treatment to a child shall seek, only with the written consent of the child, the involvement of a parent, family member, or other individual close to the child. Such involvement shall be in conformity with the confidentiality requirements of R.S. 40:1079.18.  Acts 1994, 3rd Ex. Sess., No. 18, §1, eff. July 6, 1994; Redesignated from R.S. 40:1098.5 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1079.16 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1079.16. Limitation of liability

RS 1079.16 - Limitation of liability  A. Any qualified professional who provides services in accordance with the provisions of this Subpart without the permission of one or both of the child's parents shall be presumed to be acting in good faith.  B. Any qualified professional found to be acting in good faith and in compliance with the provisions of this Subpart, and absent willful and wanton misconduct, shall be immune from any liability, civil or criminal, that might otherwise be incurred or imposed as a result of action taken pursuant to this Subpart.  Acts 1994, 3rd Ex. Sess., No. 18, §1, eff. July 6, 1994; Redesignated from R.S. 40:1098.6 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1079.17 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1079.17. Authorized resources

RS 1079.17 - Authorized resources  A school or facility may solicit and use any available state, federal, or private resources, which may include but shall not be limited to funds, in-kind resources, or volunteer services, for the purpose of providing preventive counseling services or treatment for alcohol or drug abuse.  Acts 1994, 3rd Ex. Sess., No. 18, §1, eff. July 6, 1994; Redesignated from R.S. 40:1098.7 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1079.18 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1079.18. Confidentiality

RS 1079.18 - Confidentiality  Notwithstanding any other provision of law to the contrary, the identity of persons receiving preventive counseling or treatment and all records containing information regarding the provision of preventive counseling or treatment shall be confidential. No qualified professional or employee of a school or facility providing preventive counseling or treatment shall disclose any records or information in such records containing the identity of any child receiving preventive counseling or treatment except in compliance with state and federal laws and regulations.  Acts 1994, 3rd Ex. Sess., No. 18, §1, eff. July 6, 1994; Redesignated from R.S. 40:1098.8 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1081.1 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1081.1. Programs for combating phenylketonuria, congenital hypothyroidism, galactosemia, sickle cell diseases, biotinidase deficiency, and other genetic conditions

RS 1081.1 - Programs for combating phenylketonuria, congenital hypothyroidism, galactosemia, sickle cell diseases, biotinidase deficiency, and other genetic conditions  A. The Louisiana Department of Health is hereby authorized and directed to establish, maintain, and carry out programs designed to reduce mortality and morbidity from sickle cell disease and to prevent central nervous system damage in children with phenylketonuria, congenital hypothyroidism, biotinidase deficiency, galactosemia and genetic conditions tested under the authority of R.S. 40:1081.2(B).  B.(1) The Louisiana Department of Health shall establish and maintain a diagnostic laboratory for each of the following purposes:  (a) Conducting experiments, projects, and other undertakings as may be necessary to develop tests for the early detection of phenylketonuria, congenital hypothyroidism, galactosemia, sickle cell diseases, biotinidase deficiency, and other genetic conditions.  (b) Developing ways or discovering methods to be used for the prevention and treatment of these diseases.  (c) Such other purposes as may be deemed necessary by the department to carry out any program adopted under the authority of this Subpart, including conducting experiments, projects, and other undertakings as may be necessary to develop tests for genetic conditions made part of the battery of tests by the Louisiana Department of Health under R.S. 40:1081.2(B).  (2) Notwithstanding the foregoing, the term "prevention" as used with respect to sickle cell anemia shall not mean mandatory sterilization or abortion.  C. The department is authorized to adopt rules and regulations necessary to carry out any program which may be established.  D. The Louisiana Department of Health shall establish a program for informing physicians and hospitals of the current medical standards for diagnosing and treating children who exhibit clinical symptoms which suggest the existence of galactosemia. This program shall be established in consultation with and shall be based on the recommendations of the Louisiana Hospital Association and the Louisiana State Medical Society.  Acts 1964, No. 269, §1. Amended by Acts 1978, No. 442, §2; Acts 1978, No. 786, §5, eff. July 17, 1978; Acts 1981, No. 430, §1; Acts 1982, No. 375, §1; Acts 1984, No. 265, §2; Acts 1987, No. 598, §1, eff. July 9, 1987; Acts 1989, No. 91, §1; Acts 1991, No. 729, §1; Acts 1993, No. 997, §1; Acts 1999, No. 328, §1; Redesignated from R.S. 40:1299 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1081.3 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1081.3. Cooperation with the Louisiana Department of Health

RS 1081.3 - Cooperation with the Louisiana Department of Health  The various boards, commissions, departments and agencies of the state and of the parishes, municipalities and other political subdivisions capable of assisting or having services and facilities for assisting the Louisiana Department of Health in carrying out any program established under the authority of this Subpart may cooperate with the Louisiana Department of Health and may furnish any such services and facilities in aid of any such program.  Acts 1964, No. 269, §3. Amended by Acts 1978, No. 442, §2; Acts 1978, No. 786, §5, eff. July 17, 1978; Redesignated from R.S. 40:1299.2 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1081.4 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1081.4. Cooperation of physicians and hospitals

RS 1081.4 - Cooperation of physicians and hospitals   The Louisiana Department of Health may invite the cooperation of all physicians and hospitals in the state which provide maternity and newborn infant care to participate in any program established by the department under the authority of this Subpart.  Acts 1964, No. 269, §4. Amended by Acts 1978, No. 442, §2; Acts 1978, No. 786, §5, eff. July 17, 1978; Redesignated from R.S. 40:1299.3 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1081.5 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1081.5. Sickle Cell Anemia; clinic established

RS 1081.5 - Sickle Cell Anemia; clinic established  The Louisiana Department of Health is hereby authorized and directed to establish and operate clinics in cooperation with the medical schools of Louisiana State University and Tulane University for the treatment of sickle cell anemia, in Charity Hospital of Louisiana in New Orleans and in Louisiana State Medical Center in Shreveport. The clinics shall be maintained for the treatment of victims of sickle cell anemia regardless of geographic and economic family situation without regard to the standard eligibility requirements of charity hospitals and for the training of physicians and medical students in methods of treatment and for research into the causes of the disease and its cure.  Acts 1972, No. 27, §1. Amended by Acts 1978, No. 786, §5, eff. July 17, 1978; Acts 1984, No. 265, §2; Acts 1984, No. 859, §1; Acts 1993, No. 604, §2; Redesignated from R.S. 40:1299.4 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1081.6 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1081.6. Sickle cell anemia; clinics established statewide

RS 1081.6 - Sickle cell anemia; clinics established statewide  A. The Louisiana Department of Health shall establish and operate a minimum of seven clinics for the treatment of sickle cell anemia throughout the state if and when one hundred percent federal funding becomes available for this purpose.  B. The clinics shall be established in cooperation with the medical schools of Louisiana State University and Tulane University, the state medical centers, the sickle cell anemia foundations, and the National Research Center for Sickle Cell Anemia at Southern University and Agricultural and Mechanical College at Baton Rouge and shall be located in Monroe, Shreveport, Alexandria, Lake Charles, Lafayette, Baton Rouge, and New Orleans.  C.(1) The clinics shall be maintained for the treatment of victims of sickle cell anemia and shall also provide holistic care and counseling for families of victims of sickle cell anemia. Fees for treatment shall be provided in accordance with the provisions of R.S. 46:6.  (2) For purposes of this Section, "holistic care" includes educational literature, screening, testing, treatment, and referral to appropriate persons or facilities.  D. The clinics shall develop a working rapport with the state public health clinics and substance abuse centers and the sickle cell anemia foundations and shall organize support groups within the parish and surrounding parishes where they are located.  E. Each clinic shall be staffed by a physician, nurse, and any other staff as necessary to provide treatment and other services and shall contract with at least one hematologist to serve the clinic and may cooperate and interact with other state and private institutions in order to staff the clinic.  Acts 1993, No. 604, §1; Redesignated from R.S. 40:1299.4.1 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1081.7 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1081.7. Sickle cell anemia; local programs

RS 1081.7 - Sickle cell anemia; local programs  A. The Shreveport Sickle Cell Clinic, the Northeast Louisiana Sickle Cell Foundation, the Sickle Cell Anemia Rehabilitation and Educational Program, Inc., the Alexandria Sickle Cell Program, the Eighth Regional Sickle Cell Foundation, and the Baton Rouge Sickle Cell Program, hereinafter referred to as "program", shall be maintained for the treatment of victims of sickle cell anemia regardless of geographic and economic family situation and without regard to the standard eligibility requirements of charity hospitals. In addition, the programs shall implement policies and plans to convert their individual facility into regionalized facilities, whereby each facility is responsible for sickle cell anemia patients in parishes surrounding the main facility.  B. Each program shall provide holistic care, which shall include but not be limited to educational literature, screening, testing, treatment, and referrals. If funds are available, each program shall:  (1) Provide a physician or nurse to provide proper health care.  (2) Provide a hematologist to provide proper testing to sickle cell anemia patients.  (3) Provide counseling for families of those who are affected by sickle cell anemia and which fatality appears imminent.  (4) The executive director of each regional sickle cell anemia clinic shall possess the minimum qualifications established by rules promulgated by the Louisiana Department of Health.  C. The provisions of this Section shall not relieve or remove any responsibilities of the Louisiana Department of Health from implementing and complying with the provisions of R.S. 40:1081.5.  D. The provisions of this Section shall be implemented if and when one hundred percent federal funds are made available for the purposes set forth in this Section.  Acts 1993, No. 605, §1; Redesignated from R.S. 40:1299.4.2 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1081.8 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1081.8. Sickle cell patient navigator program

RS 1081.8 - Sickle cell patient navigator program  A. The legislature hereby finds and declares the following:  (1) A large percentage of persons suffering from sickle cell disease in this state are not in specialty care, even though the health consequences of going without such care may be fatal.  (2) Insufficient access to specialty care is a major barrier to overall health care for persons suffering from sickle cell disease.  (3) The purpose of this Section is to provide for a program to increase statewide access to the types of specialty care that are critical to the health and well-being of sickle cell patients.  B. The Sickle Cell Patient Navigator Program, referred to hereafter in this Section as "the program", is hereby established. The program shall operate in accordance with the provisions of this Section.  C. The functions of the program shall include, without limitation, all of the following:  (1) Training of patient navigators to serve as outreach coordinators, coordinators of family educational sessions, and patient case managers.  (2) Establishing and strengthening a continuum of care for each sickle cell patient served by the program and for the families of those patients.  (3) Identifying and contacting sickle cell patients, conducting home visits with patients and their family members, and coordinating patient care.  (4) Facilitating collaboration among healthcare providers that serve sickle cell patients.  (5) Delivering public health education on sickle cell disease and treatment.  D. The Louisiana Department of Health shall administer the program under the direction of the Louisiana Sickle Cell Commission placed within the department by the provisions of R.S. 36:259(B)(13).  E. This Section and the Sickle Cell Patient Navigator Program shall not be implemented or operational until monies have been appropriated by the legislature sufficient to fully fund these provisions.  Acts 2015, No. 387, §§1, 2.
LA Rev Stat § 40:1081.9 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1081.9. Hemophilia; state treatment program; advisory committee

RS 1081.9 - Hemophilia; state treatment program; advisory committee  A. As used in this Section:  (1) "Department" shall mean the Louisiana Department of Health, or its successor.  (2) "Hemophilia" shall mean a bleeding tendency resulting from a genetically determined deficiency factor in the blood.  (3) "Hemophiliac" shall mean a person suffering from hemophilia.  (4) "Secretary" shall mean the secretary of the Louisiana Department of Health, or his designated representative.  B. The Louisiana Department of Health shall establish a program for the care and treatment of persons suffering from hemophilia. This program shall assist persons who require continuing treatment with blood and blood derivatives to avoid crippling, extensive hospitalization and other effects associated with the critical, chronic bleeding condition called hemophilia, but who are unable to pay for the entire cost of such services on a continuing basis despite the existence of various types of hospital coverages, Medicare, Medicaid, other government assistance programs, and private charitable assistance programs.  C. The department shall:  (1) Develop standards for determining eligibility for care and treatment under this program.  (2) Extend financial assistance to hemophiliacs in obtaining blood and blood derivatives and concentrates, and other efficacious agents for use in hospitals, medical and dental facilities, and at home, or participate in the cost of blood processing to the extent that such support will facilitate the supplying of blood, blood derivatives and concentrates, and other efficacious agents to hemophiliac patients at an economical cost, thus increasing the effectiveness of the monies appropriated to carry out the provisions of this Section.  (3) Institute and maintain educational programs among physicians, dentists, hospitals, public health departments, schools, and the public concerning hemophilia, including dissemination of information and the conducting of educational programs concerning the methods of care and treatment of persons suffering from hemophilia.  (4) Promulgate all rules and regulations necessary to effectuate the purposes of this Section.  D. Funds shall be made available under this program without regard to race or age.  Added by Acts 1977, No. 292, §1, eff. July 13, 1977; Redesignated from R.S. 40:1299.5 by HCR 84 of 2015 R.S; Acts 2018, No. 206, §4.
LA Rev Stat § 40:1081.10 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1081.10. Privacy of genetic information

RS 1081.10 - Privacy of genetic information  With the exception of genetic tests specifically mandated to be reported by law, the results of any prenatal or postnatal genetic tests shall be confidential medical information and shall be excluded from reporting requirements. The results of such genetic tests shall become part of the medical record of the person tested and shall be confidential unless express written consent to their release is granted by the person tested.  Acts 1995, No. 1194, §1; Redesignated from R.S. 40:1299.6 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1081.11 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1081.11. Krabbe disease; public information

RS 1081.11 - Krabbe disease; public information  A. The Louisiana Department of Health shall develop and maintain information regarding Krabbe disease on its website.  B. The information provided by the department pursuant to this Section shall include, at a minimum, all of the following:  (1) An explanation of Krabbe disease symptoms, diagnosis, and treatment options.  (2) Information on relevant state agency and nonprofit resources, parent support groups, and available Medicaid waiver services.  Acts 2016, No. 507, §1.
LA Rev Stat § 40:1083.1 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1083.1. Definitions

RS 1083.1 - Definitions  A. "Birthing facility" means an inpatient or ambulatory health care facility licensed by the Louisiana Department of Health that provides birthing and newborn care services.  B. "Congenital heart defects" (CHD) means structural abnormalities of the heart that are present at birth and range in severity from simple problems, such as holes between chambers of the heart, to severe malfunctions, such as the complete absence of one or more chambers or valves. CHD is the most common birth defect and is the number one cause of infant death from birth defects.  C. "Critical congenital heart disease" (CCHD) means a heart defect that causes severe, life-threatening symptoms and requires intervention, such as surgery, in the first few hours, days, or months of life. CCHD accounts for about twenty-five percent of all CHD.  D. "Pulse Oximetry Screening" means a noninvasive test that estimates the percentage of hemoglobin in blood that is saturated with oxygen to detect CHDs.  Acts 2013, No. 407, §1; Redesignated from R.S. 40:1300.371 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1083.2 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1083.2. Legislative intent

RS 1083.2 - Legislative intent  The legislature finds that:  (1) Critical congenital heart disease can cause severe and life-threatening symptoms that require intervention within the first days of life. Early detection of CCHD and timely intervention can decrease morbidity and mortality and lead to better outcomes for affected children.  (2) According to the Centers for Disease Control and Prevention (CDC), CHDs occur in approximately one in one hundred ten births in the United States. About twenty-five percent of CHDs are considered CCHDs.  (3) Current methods for detecting CCHDs generally include prenatal ultrasound screening and repeated clinical examinations. Defects are also often not detected during routine clinical exams performed prior to a newborn baby's discharge from a birthing facility.  (4) When a screening for CCHD, such as pulse oximetry screening, is performed on a newborn in a birthing facility, it is effective in detecting life-threatening CHDs, which otherwise go undetected by current screening methods. The use of pulse oximetry in newborn nurseries is standard in most hospitals.  (5) Newborns with abnormal pulse oximetry results require immediate testing to confirm a defect and allow intervention. Many newborns could be saved by earlier detection and treatment of CCHD if birthing facilities in the state of Louisiana were required to perform this simple, noninvasive newborn screening in conjunction with current CCHD screening methods.  Acts 2013, No. 407, §1; Redesignated from R.S. 40:1300.372 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1083.3 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1083.3. Critical congenital heart disease screening

RS 1083.3 - Critical congenital heart disease screening  Each birthing facility in the state of Louisiana shall perform pulse oximetry screening for the identification of CCHD on every newborn in its care prior to discharge from the birthing facility, unless prohibited by the parent or guardian of the newborn.  Acts 2013, No. 407, §1; Redesignated from R.S. 40:1300.373 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1085.1 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1085.1. Ophthalmia neonatorum defined

RS 1085.1 - Ophthalmia neonatorum defined  Any eye condition of any infant, in which there is any inflammation, swelling, or redness in one or both eyes, with or without any unnatural discharge from the eye or eyes, occurring within two weeks after the birth of the infant, shall be known as ophthalmia neonatorum, independent of the nature of the infection.  Redesignated from R.S. 40:1101 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1085.2 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1085.2. Duty to report disease to local health officer

RS 1085.2 - Duty to report disease to local health officer  Any physician, midwife, or other person licensed by the state to practice obstetrics or to assist at childbirth, or any physician who attends a child within two weeks after childbirth, shall within six hours after obtaining knowledge of the condition defined in R.S. 40:1085.1 report this condition, as directed by the Louisiana Department of Health, hereinafter referred to as the "department", to the local health officer at the residence of the mother.  Amended by Acts 1978, No. 786, §5, eff. July 17, 1978; Acts 1988, No. 839, §1; Redesignated from R.S. 40:1102 by HCR 84 of 2015 R.S.
LA Rev Stat § 40:1085.3 (2021)
2021 Louisiana Laws|Revised Statutes|Title 40 - Public Health and Safety|§1085.3. Use of prophylactic directed by department

RS 1085.3 - Use of prophylactic directed by department  A. All persons covered by the provisions of R.S. 40:1085.2 shall routinely apply or be reasonably certain that others have already applied any prophylactic which the department directs for the prevention of ophthalmia neonatorum, whether or not ophthalmia neonatorum is indicated, and to do so in the manner that the department directs. The provisions of this Section shall be inoperative in those instances where:  (1) There are no indications of the existence of ophthalmia neonatorum; and  (2) The mother states in writing that she objects to the application of such prophylactic on religious grounds.  B. Liability arising from the lack of use of the approved prophylactic shall not attach to any person or institution who, on the written instruction of the mother, withholds the application of the approved prophylactic.  Amended by Acts 1978, No. 786, §5, eff. July 17, 1978; Acts 1988, No. 839, §1; Redesignated from R.S. 40:1103 by HCR 84 of 2015 R.S.